Phase III trial of rosiptor in interstitial cystitis/bladder pain syndrome misses primary endpoint June 27, 2018
Aquinox initiates phase II study of rosiptor in chronic prostatitis/chronic pelvic pain syndrome June 12, 2018
Pfizer initiates phase II study of PF-06730512 in primary focal segmental glomerulosclerosis June 11, 2018
Bardoxolone methyl receives orphan drug designation in Europe for the treatment of Alport syndrome June 4, 2018
RSS